Bollard Group LLC lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 75,089 shares of the biopharmaceutical company’s stock after selling 3,640 shares during the period. Bollard […]